Molecular determinants of acquired resistance to BRAF inhibition in human lung cancer

被引:1
|
作者
Lucchesi, Carlo [1 ]
Drogat, Benjamin [2 ]
Santamaria, David
Cousin, Sophie [3 ]
Italiano, Antoine [1 ,3 ,4 ]
机构
[1] Inst Bergonie, INSERM, U1218, 229 Cours Argonne, F-33076 Bordeaux, France
[2] Univ Bordeaux, INSERM, U1218, ACT Lab,IECB, F-33600 Pessac, France
[3] Inst Bergonie, Early Phase Trials Unit, 229 Cours Argonne, F-33076 Bordeaux, France
[4] Univ Bordeaux, Bordeaux, France
关键词
D O I
10.1016/j.lungcan.2018.10.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:227 / 229
页数:3
相关论文
共 50 条
  • [1] Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer
    Lin, Luping
    Asthana, Saurabh
    Chan, Elton
    Bandyopadhyay, Sourav
    Martins, Maria M.
    Olivas, Victor
    Yan, Jenny Jiacheng
    Pham, Luu
    Wang, Mingxue Michelle
    Bollag, Gideon
    Solit, David B.
    Collisson, Eric A.
    Rudin, Charles M.
    Taylor, Barry S.
    Bivona, Trever G.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (07) : E748 - E757
  • [2] Molecular determinants of acquired resistance
    De Jong, S.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 50 - 51
  • [3] Acquired Resistance to BRAF Inhibition Can Confer Cross-Resistance to Combined BRAF/MEK Inhibition
    Gowrishankar, Kavitha
    Snoyman, Stephanie
    Pupo, Gulietta M.
    Becker, Therese M.
    Kefford, Richard F.
    Rizos, Helen
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (07) : 1850 - 1859
  • [4] Molecular Characterization of Acquired Resistance to the BRAF Inhibitor Dabrafenib in a Patient with BRAF-Mutant Non-Small-Cell Lung Cancer
    Rudin, Charles M.
    Hong, Kelvin
    Streit, Michael
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (05) : E41 - E42
  • [5] Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines
    Noordhuis, Paul
    Laan, Adrianus C.
    van de Born, Kasper
    Honeywell, Richard J.
    Peters, Godefridus J.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (15)
  • [6] Molecular determinants of UCN-01-induced growth inhibition in human lung cancer cells
    Usuda, J
    Saijo, N
    Fukuoka, K
    Fukumoto, H
    Kuh, HJ
    Nakamura, T
    Koh, Y
    Suzuki, T
    Koizumi, F
    Tamura, T
    Kato, H
    Nishio, K
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2000, 85 (02) : 275 - 280
  • [7] Acquired Resistance in Lung Cancer
    Tulpule, Asmin
    Bivona, Trever G.
    [J]. ANNUAL REVIEW OF CANCER BIOLOGY, VOL 4, 2020, 4 : 279 - 297
  • [8] Acquired resistance in lung cancer
    Pamela Feliciano
    [J]. Nature Genetics, 2012, 44 (3) : 241 - 241
  • [9] Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer
    Oddo, Daniele
    Sennott, Erin M.
    Barault, Ludovic
    Valtorta, Emanuele
    Arena, Sabrina
    Cassingena, Andrea
    Filiciotto, Genny
    Marzolla, Giulia
    Elez, Elena
    van Geel, Robin M. J. M.
    Bartolini, Alice
    Crisafulli, Giovanni
    Boscaro, Valentina
    Godfrey, Jason T.
    Buscarino, Michela
    Cancelliere, Carlotta
    Linnebacher, Michael
    Corti, Giorgio
    Truini, Mauro
    Siravegna, Giulia
    Grasselli, Julieta
    Gallicchio, Margherita
    Bernards, Rene
    Schellens, Jan H. M.
    Tabernero, Josep
    Engelman, Jeffrey A.
    Sartore-Bianchi, Andrea
    Bardelli, Alberto
    Siena, Salvatore
    Corcoran, Ryan B.
    Di Nicolantonio, Federica
    [J]. CANCER RESEARCH, 2016, 76 (15) : 4504 - 4515
  • [10] Overcoming acquired resistance to kinase inhibition: The cases of EGFR, ALK and BRAF
    Giroux, Simon
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (02) : 394 - 401